These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 24841294)

  • 21. The FGF21 response to fructose predicts metabolic health and persists after bariatric surgery in obese humans.
    Ter Horst KW; Gilijamse PW; Demirkiran A; van Wagensveld BA; Ackermans MT; Verheij J; Romijn JA; Nieuwdorp M; Maratos-Flier E; Herman MA; Serlie MJ
    Mol Metab; 2017 Nov; 6(11):1493-1502. PubMed ID: 29107295
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum concentrations and tissue expression of a novel endocrine regulator fibroblast growth factor-21 in patients with type 2 diabetes and obesity.
    Mraz M; Bartlova M; Lacinova Z; Michalsky D; Kasalicky M; Haluzikova D; Matoulek M; Dostalova I; Humenanska V; Haluzik M
    Clin Endocrinol (Oxf); 2009 Sep; 71(3):369-75. PubMed ID: 19702724
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Altered promoter methylation of PDK4, IL1 B, IL6, and TNF after Roux-en Y gastric bypass.
    Kirchner H; Nylen C; Laber S; Barrès R; Yan J; Krook A; Zierath JR; Näslund E
    Surg Obes Relat Dis; 2014; 10(4):671-8. PubMed ID: 24837562
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of gastric bypass versus diet on cardiovascular risk factors.
    Raffaelli M; Guidone C; Callari C; Iaconelli A; Bellantone R; Mingrone G
    Ann Surg; 2014 Apr; 259(4):694-9. PubMed ID: 23979288
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Postprandial metabolite profiles reveal differential nutrient handling after bariatric surgery compared with matched caloric restriction.
    Khoo CM; Muehlbauer MJ; Stevens RD; Pamuklar Z; Chen J; Newgard CB; Torquati A
    Ann Surg; 2014 Apr; 259(4):687-93. PubMed ID: 23787216
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Perturbations of fibroblast growth factors 19 and 21 in type 2 diabetes.
    Roesch SL; Styer AM; Wood GC; Kosak Z; Seiler J; Benotti P; Petrick AT; Gabrielsen J; Strodel WE; Gerhard GS; Still CD; Argyropoulos G
    PLoS One; 2015; 10(2):e0116928. PubMed ID: 25664662
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Roux-en-Y gastric bypass compared with aggressive diet and exercise therapy for morbidly obese patients awaiting renal transplant: a decision analysis.
    Choudhury RA; Murayama KM; Abt PL; Glick HA; Naji A; Williams NN; Dumon KR
    Surg Obes Relat Dis; 2014; 10(1):79-87. PubMed ID: 24139923
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metabolomics Study of Roux-en-Y Gastric Bypass Surgery (RYGB) to Treat Type 2 Diabetes Patients Based on Ultraperformance Liquid Chromatography-Mass Spectrometry.
    Luo P; Yu H; Zhao X; Bao Y; Hong CS; Zhang P; Tu Y; Yin P; Gao P; Wei L; Zhuang Z; Jia W; Xu G
    J Proteome Res; 2016 Apr; 15(4):1288-99. PubMed ID: 26889720
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improved glucose metabolism following bariatric surgery is associated with increased circulating bile acid concentrations and remodeling of the gut microbiome.
    Kaska L; Sledzinski T; Chomiczewska A; Dettlaff-Pokora A; Swierczynski J
    World J Gastroenterol; 2016 Oct; 22(39):8698-8719. PubMed ID: 27818587
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanisms of Action of Surgical Interventions on Weight-Related Diseases: the Potential Role of Bile Acids.
    Mazidi M; de Caravatto PP; Speakman JR; Cohen RV
    Obes Surg; 2017 Mar; 27(3):826-836. PubMed ID: 28091894
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reduction in serum fibroblast growth factor-21 after gastric bypass is related to changes in hepatic fat content.
    Fjeldborg K; Pedersen SB; Møller HJ; Richelsen B
    Surg Obes Relat Dis; 2017 Sep; 13(9):1515-1523. PubMed ID: 28552744
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is sleeve gastrectomy as effective as gastric bypass for remission of type 2 diabetes in morbidly obese patients?
    de Gordejuela AG; Pujol Gebelli J; García NV; Alsina EF; Medayo LS; Masdevall Noguera C
    Surg Obes Relat Dis; 2011; 7(4):506-9. PubMed ID: 21411376
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acute and long-term effects of Roux-en-Y gastric bypass on glucose metabolism in subjects with Type 2 diabetes and normal glucose tolerance.
    Jørgensen NB; Jacobsen SH; Dirksen C; Bojsen-Møller KN; Naver L; Hvolris L; Clausen TR; Wulff BS; Worm D; Lindqvist Hansen D; Madsbad S; Holst JJ
    Am J Physiol Endocrinol Metab; 2012 Jul; 303(1):E122-31. PubMed ID: 22535748
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hormonal changes after Roux-en Y gastric bypass for morbid obesity and the control of type-II diabetes mellitus.
    Clements RH; Gonzalez QH; Long CI; Wittert G; Laws HL
    Am Surg; 2004 Jan; 70(1):1-4; discussion 4-5. PubMed ID: 14964537
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum fibroblast growth factor 21 was elevated in subjects with type 2 diabetes mellitus and was associated with the presence of carotid artery plaques.
    An SY; Lee MS; Yi SA; Ha ES; Han SJ; Kim HJ; Kim DJ; Lee KW
    Diabetes Res Clin Pract; 2012 May; 96(2):196-203. PubMed ID: 22293928
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum retinol-binding protein 4 is not increased in obesity or obesity-associated type 2 diabetes mellitus, but is reduced after relevant reductions in body fat following gastric bypass.
    Gómez-Ambrosi J; Rodríguez A; Catalán V; Ramírez B; Silva C; Rotellar F; Gil MJ; Salvador J; Frühbeck G
    Clin Endocrinol (Oxf); 2008 Aug; 69(2):208-15. PubMed ID: 18081728
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of the incretin system in the remission of type 2 diabetes following bariatric surgery.
    Mingrone G
    Nutr Metab Cardiovasc Dis; 2008 Oct; 18(8):574-9. PubMed ID: 18790374
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuro-modulation and bariatric surgery for type 2 diabetes mellitus.
    Spector D; Shikora S
    Int J Clin Pract Suppl; 2010 Feb; (166):53-8. PubMed ID: 20377665
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reduction in endotoxemia, oxidative and inflammatory stress, and insulin resistance after Roux-en-Y gastric bypass surgery in patients with morbid obesity and type 2 diabetes mellitus.
    Monte SV; Caruana JA; Ghanim H; Sia CL; Korzeniewski K; Schentag JJ; Dandona P
    Surgery; 2012 Apr; 151(4):587-93. PubMed ID: 22088821
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bariatric surgery in severely obese adolescents improves major comorbidities including hyperuricemia.
    Oberbach A; Neuhaus J; Inge T; Kirsch K; Schlichting N; Blüher S; Kullnick Y; Kugler J; Baumann S; Till H
    Metabolism; 2014 Feb; 63(2):242-9. PubMed ID: 24332707
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.